Literature DB >> 27856512

Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study.

Maria Chiara Tisi1, Stefan Hohaus2, Annarosa Cuccaro2, Idanna Innocenti2, Elena De Carolis3, Tommaso Za2, Francesco D'Alò2, Luca Laurenti2, Luana Fianchi2, Simona Sica2, Maurizio Sanguinetti3, Valerio De Stefano2, Livio Pagano2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27856512      PMCID： PMC5394967          DOI： 10.3324/haematol.2016.151837

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.

Authors:  J Moreira; K G Rabe; J R Cerhan; N E Kay; J W Wilson; T G Call; J F Leis; D F Jelinek; S M Schwager; D A Bowen; C A Hanson; S L Slager; T D Shanafelt
Journal:  Leukemia       Date:  2012-07-11       Impact factor: 11.528

2.  The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.

Authors:  Livio Pagano; Morena Caira; Anna Candoni; Massimo Offidani; Luana Fianchi; Bruno Martino; Domenico Pastore; Marco Picardi; Alessandro Bonini; Anna Chierichini; Rosa Fanci; Cecilia Caramatti; Rosangela Invernizzi; Daniele Mattei; Maria Enza Mitra; Lorella Melillo; Franco Aversa; Maria Teresa Van Lint; Paolo Falcucci; Caterina Giovanna Valentini; Corrado Girmenia; Annamaria Nosari
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

3.  Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China.

Authors:  Yuqian Sun; He Huang; Jing Chen; Jianyong Li; Jun Ma; Juan Li; Yingmin Liang; Jianmin Wang; Yan Li; Kang Yu; Jianda Hu; Jie Jin; Chun Wang; Depei Wu; Yang Xiao; Xiaojun Huang
Journal:  Tumour Biol       Date:  2014-10-08

4.  Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide.

Authors:  Massimo Offidani; Laura Corvatta; Claudia Polloni; Silvia Gentili; Annamaria Brioni; Giuseppe Visani; Piero Galieni; Marino Brunori; Francesco Alesiani; Massimo Catarini; Riccardo Centurioni; Arduino Samori; Nicola Blasi; Mario Ferranti; Paolo Fraticelli; Anna Mele; Rita Rizzi; Federica Larocca; Pietro Leoni
Journal:  Leuk Lymphoma       Date:  2011-02-21

5.  The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.

Authors:  Sebastian Francis; Mamatha Karanth; Guy Pratt; Jane Starczynski; Laura Hooper; Chris Fegan; Chris Pepper; David Valcarcel; Donald W Milligan; Julio Delgado
Journal:  Cancer       Date:  2006-09-01       Impact factor: 6.860

6.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

7.  Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.

Authors:  Junru Liu; He Huang; Yan Li; Lin Liu; Jianyong Li; Zhuogang Liu; Jin Lu; Jian Ouyang; Yongping Song; Daobin Zhou; Hanyun Ren; Jun Ma; Chun Wang; Li Yu; Jin Zhou; Jianmin Wang; Yang Xiao; Xiaojun Huang; Juan Li
Journal:  Tumour Biol       Date:  2015-12-23

8.  Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.

Authors:  Benjamin W Teh; Jasmine C Teng; Karin Urbancic; Andrew Grigg; Simon J Harrison; Leon J Worth; Monica A Slavin; Karin A Thursky
Journal:  Haematologica       Date:  2014-10-10       Impact factor: 9.941

9.  Drug-induced modulation of T lymphocytes as a potential mechanism of susceptibility to infections in patients with multiple myeloma during bortezomib therapy.

Authors:  Juan Li; Ying Li; Beihui Huang; Dong Zheng; Mei Chen; Zhenhai Zhou
Journal:  Cell Biochem Biophys       Date:  2015-01       Impact factor: 2.194

10.  A risk prediction score for invasive mold disease in patients with hematological malignancies.

Authors:  Marta Stanzani; Russell E Lewis; Mauro Fiacchini; Paolo Ricci; Fabio Tumietto; Pierluigi Viale; Simone Ambretti; Michele Baccarani; Michele Cavo; Nicola Vianelli
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240
View more
  16 in total

1.  Clinical Spectrum, Diagnosis and Outcome of Rare Fungal Infections in Patients with Hematological Malignancies: Experience of 15-Year Period from a Single Tertiary Medical Center.

Authors:  Emilia Hardak; Eyal Fuchs; Yuval Geffen; Tsila Zuckerman; Ilana Oren
Journal:  Mycopathologia       Date:  2020-02-25       Impact factor: 2.574

2.  Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.

Authors:  Georgios Chamilos; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

3.  Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study.

Authors:  Andrea Visentin; Vincenzo Nasillo; Monia Marchetti; Isacco Ferrarini; Rossella Paolini; Rosaria Sancetta; Gian Matteo Rigolin; Francesca Cibien; Marcello Riva; Chiara Briani; Serena Marinello; Francesco Piazza; Filippo Gherlinzoni; Mauro Krampera; Renato Bassan; Antonio Cuneo; Mario Luppi; Gianpietro Semenzato; Roberto Marasca; Livio Trentin
Journal:  Hemasphere       Date:  2020-06-08

Review 4.  Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs.

Authors:  Davide Facchinelli; Gessica Marchesini; Gianpaolo Nadali; Livio Pagano
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

Review 5.  Prophylaxis of mould infections.

Authors:  E Moreno-García; M Chumbita; P Puerta-Alcalde; C Cardozo; C García-Vidal
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

6.  Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus.

Authors:  Damien Blez; Marion Blaize; Carole Soussain; Alexandre Boissonnas; Aïda Meghraoui-Kheddar; Natacha Menezes; Anaïs Portalier; Christophe Combadière; Véronique Leblond; David Ghez; Arnaud Fekkar
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

7.  Life-Threatening Fungal Infection in Richter Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Case Report and Brief Review of Literature.

Authors:  Binav Baral; Kriti Ahuja; Navika Chhabra; Muhammad J Tariq; Maryam Zia
Journal:  Cureus       Date:  2021-06-25

8.  Chemotherapy-related infectious complications in patients with Hematologic malignancies.

Authors:  Raluca-Ana Rusu; Dana Sîrbu; Daniela Curşeu; Bogdana Năsui; Mădălina Sava; Ştefan Cristian Vesa; Anca Bojan; Cosmin Lisencu; Monica Popa
Journal:  J Res Med Sci       Date:  2018-07-26       Impact factor: 1.852

9.  Update in Infectious Diseases 2019.

Authors:  F J Candel; C M Rico; I Díaz de la Torre; B Laguna; J Martínez-Jordán; S Medrano; M C Escobar-Porcel; A López-Delgado; L López-González; J M Viñuela-Prieto; M Matesanz; J González Del Castillo; A Arribi
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

Review 10.  Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Justin T Low; Katherine B Peters
Journal:  CNS Oncol       Date:  2020-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.